Stanford University — Stanford, California

Public research footprint of Stanford University, compiled from the ClinicalTrials.gov public registry.

2,518

Registered studies

434

Active

215

Recruiting now

1,600

Completed

408

Stopped or withdrawn

Most-studied conditions

Depression - Major Depressive Disorder · PDAC - Pancreatic Ductal Adenocarcinoma · Heart Failure With Reduced Ejection Fraction · Type 2 Diabetes Mellitus (T2DM)

Recently updated registry entries

NCT06948097 — Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the… (Not Yet Recruiting)
NCT06305780 — RECOVER-AUTONOMIC Platform Protocol (Completed)
NCT06793397 — A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stanford University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.